Information

General Information
Australasian Tissue Banks & Cell Therapy facilities associated with the BAA manufacture the following biotherapeutic products for implant:
  • musculoskeletal tissues (e.g. bones, tendons, ligaments),
  • cardiovascular tissues (e.g. heart valves, pericardium, vascular tissue),
  • skin (e.g. split thickness allografts),
  • amnion (e.g. membrane grafts) and
  • cellular biotherapeutic products (e.g. mesenchymal stromal cells).
All of these products are derived from Australian donors and manufactured in Australia. Our Tissue Banks are regulated and licensed by the Therapeutics Goods Administration (TGA) and our products are listed on the Australian Register of Therapeutic Goods (ARTG). Our products also meet extensive tracking, traceability and biovigilance criteria to ensure they are of the highest quality and safety for recipients.

Media

ABCNews - Open Heart
ABCNews - Skin donation shortage leaving bushfire victims at risk, tissue bank warns

Standard Terminology for Medical Products of Human Origin (NEW!)

ICCBBA is pleased to announce that the new bone terminology has been published in the ISBT 128 Standard Terminology for Medical Products of Human Origin.

Forms

Downloadable application forms.
BAA Membership Application Form
Rules of the Biotherapeutics Association of Australasia 2015
BAA Certificate of Incorporation

Position Statements

Fiona Nash OTA Support Statement
ISBT Support Statement

Tissue Donation

PlusLife (video link) - Harry's Story
PlusLife (vidoe link) - Jenni's Story

Archive

ATBF Statement on Recent Media Stories

AGM, EDUCATION SESSION AND TGA WORKSHOP

BAA Conference 2017, to be held in NZ 1-3 November 2017. Click here for more information.

Keep an eye on this space!

LATEST DOCUMENT UPDATES
LATEST FORUM UPDATES
AFFILIATES